Status:
RECRUITING
Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
NSCLC (Advanced Non-small Cell Lung Cancer)
Adaptive Radiotherapy
Eligibility:
All Genders
Phase:
NA
Brief Summary
Locally advanced non-small cell lung cancer (LA-NSCLC) patients could benefit in overall and progression-free survival from regular dosimetric treatment plan adaptations during radiotherapy. This is k...
Detailed Description
Lung cancer ranks among the most commonly occurring cancer types globally and has the highest mortality rate. Non-small-cell lung cancer (NSCLC) is the predominant form, accounting for more than 85% o...
Eligibility Criteria
Inclusion Criteria:
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
- Patients diagnosed with non-small-cell lung cancer
- Locally advanced disease (≥Stage III)
- Treated with sequential or concurrent chemoradiotherapy
Exclusion Criteria:
- Small-cell lung cancer
- Non-small-cell lung cancer of early stage
- Mesothelioma
Key Trial Info
Start Date :
June 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07259447
Start Date
June 21 2024
End Date
December 31 2026
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000